NRAS and melanoma: Recently, a tight interaction between PPP6C-AurkA and MAPK pathways in controlling proliferative activity and apoptosis in melanoma cells has been demonstrated, contributing to increase the levels of tumor heterogeneity and conferring a resistance signature in BRAF- and NRAS-mutated melanomas [69, 70].